Publication:
Serum IL-23 levels in patients with vitiligo

No Thumbnail Available
Date
2014-12-01T00:00:00Z
Authors
Cengiz, FATMA PELİN
Emiroglu, NAZAN
CEMIL, Bengu Cevirgen
ERDEM, Ummu Gul Bahar
KEMERIZ, Funda
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
Background and Design: Interleukin-23 (IL-23) is a cytokine which is believed to have an important role in the pathogenesis of autoimmune diseases. Therefore, it can be used as a target molecule in the treatment of autoimmune diseases. The aim of our study was to determine serum IL-23 levels in patients with vitiligo to understand their possible roles in the disease etiology and to compare the results with the healthy controls.
Description
Keywords
Citation
Cengiz F. P. , Emiroglu N., CEMIL B. C. , ERDEM U. G. B. , KEMERIZ F., -Serum IL-23 levels in patients with vitiligo-, TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY, cilt.48, ss.204-207, 2014
Collections
Sustainable Development Goals